World Health Organization. (2021). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO.
[2]
Louis, D.N., et al. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-Oncology, 23(8), 1231-1251.
[3]
Kaley, T., & Barani, I. (2020). Meningiomas. In: Niederhuber JE, et al., editors. Abeloff's Clinical Oncology. 6th ed. Philadelphia: Elsevier.
[4]
Rogers, L., et al. (2015). Meningiomas: knowledge base, treatment outcomes, and uncertainties. International Journal of Radiation Oncology, Biology, Physics, 92(4), 710-724.
[5]
Bruna, J., et al. (2021). Leptomeningeal carcinomatosis: prognostic value of clinical imaging and cerebrospinal fluid cytology. Acta Neurologica Scandinavica, 144(3), 298-308.
[6]
Klekamp, J., & Samii, M. (2018). Surgical results for spinal meningiomas. Neurosurgery, 83(2), 217-230.
[7]
Marosi, C., et al. (2018). Malignant meningioma. Journal of Neuro-Oncology, 139(1), 1-7.
[8]
Kaur, G., et al. (2015). Programmable intrathecal pumps for the management of pain in leptomeningeal carcinomatosis. Pain Medicine, 16(6), 1100-1107.